Position in NVS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$994,231
+$60,623 QoQ
Shares Held
6,344
+3.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#619
of 1,603 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUST POINT INC. holds $18,783,056 across 10 Drug Manufacturers - General names. NVS ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,181 | $6,395,217 | |
| 2 | LLY |
ELI LILLY & Co
|
2,996 | $3,593,491 | |
| 3 | ABBV |
AbbVie Inc.
|
10,133 | $2,549,867 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,851 | $1,908,353 | |
| 5 | PFE |
Pfizer Inc
|
67,683 | $1,629,806 | |
| 6 | NVS |
Novartis AG
This page
|
6,344 | $994,231 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,912 | $801,609 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,505 | $442,821 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $994,231 | 6,344 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $933,608 | 6,112 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $757,733 | 5,496 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $704,807 | 5,496 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $665,070 | 5,496 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $612,694 | 5,496 | Shares | Sole | 2025-04-17 | |
| No filing history on record for this holder in this stock. | ||||||